Butoxamine hydrochloride | CAS#5696-15-1 | beta-2 selective adrenergic antagonist

Butoxamine hydrochloride
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592574

CAS#: 5696-15-1

Description: Butoxamine hydrochloride is a beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize beta-2 receptor involvement and identify beta-2 receptors..

Chemical Structure

Butoxamine hydrochloride

CAS# 5696-15-1

Instruction

Theoretical Analysis

MedKoo Cat#: 592574
Name: Butoxamine hydrochloride
CAS#: 5696-15-1
Chemical Formula: C15H26ClNO3
Exact Mass: 303.16
Molecular Weight: 0.000
Elemental Analysis: C, 59.30; H, 8.63; Cl, 11.67; N, 4.61; O, 15.80

Price and Availability

Size	Price	Availability	Quantity
50mg	USD 340
500mg	USD 1000
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Butoxamine hydrochloride; NSC 106565; NSC-106565; NSC106565

IUPAC/Chemical Name: alpha-(1-(tert-Butylamino)ethyl)-2,5-dimethoxybenzyl alcohol hydrochloride

InChi Key: URPAECSKKQLCII-UHFFFAOYSA-N

InChi Code: InChI=1S/C15H25NO3.ClH/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6;/h7-10,14,16-17H,1-6H3;1H

SMILES Code: COC1=CC=C(OC)C(C(O)C(NC(C)(C)C)C)=C1.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 0.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Arai M, Sato T, Takeuchi S, Goto S, Togari A. Dose effects of butoxamine, a selective β2-adrenoceptor antagonist, on bone metabolism in spontaneously hypertensive rat. Eur J Pharmacol. 2013 Feb 15;701(1-3):7-13. doi: 10.1016/j.ejphar.2012.12.016. Epub 2013 Jan 12. PubMed PMID: 23321373.

2: Sato T, Miyazawa K, Suzuki Y, Mizutani Y, Uchibori S, Asaoka R, Arai M, Togari A, Goto S. Selective β2-adrenergic Antagonist Butoxamine Reduces Orthodontic Tooth Movement. J Dent Res. 2014 Aug;93(8):807-12. doi: 10.1177/0022034514536730. Epub 2014 May 27. PubMed PMID: 24868013; PubMed Central PMCID: PMC4293756.

3: Gulia KK, Mallick HN, Kumar VM. Atenolol or butoxamine injection at the lateral septum doesn't inhibit male sexual behavior in rats. Indian J Physiol Pharmacol. 2005 Jan;49(1):103-7. PubMed PMID: 15881867.

4: Shibouta Y, Nishikawa K, Kikuchi S, Shimamoto K. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats. Eur J Pharmacol. 1979 Jan 1;53(2):201-8. PubMed PMID: 759198.

5: Pei Y, Bai X, Dong H, Han H, Zhang Z, Dong H, Hou L, Xiong L. β2-adrenergic receptor antagonist butoxamine partly abolishes the protection of 100% oxygen treatment against zymosan-induced generalized inflammation in mice. Shock. 2011 Sep;36(3):272-8. doi: 10.1097/SHK.0b013e31822413a4. PubMed PMID: 21617579.

6: Montastruc JL, Montastruc P. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog. Arch Int Pharmacodyn Ther. 1980 Jan;243(1):132-8. PubMed PMID: 7387255.

7: Wu MJ, Shin DH, Kim MY, Park CG, Kim YD, Lee J, Park IK, Choi S, So I, Park JS, Jun JY. Functional effects of β3-adrenoceptor on pacemaker activity in interstitial cells of Cajal from the mouse colon. Eur J Pharmacol. 2015 May 5;754:32-40. doi: 10.1016/j.ejphar.2015.02.031. Epub 2015 Feb 25. PubMed PMID: 25725113.

8: Lenselink DR, Kuhlmann RS, Lawrence JM, Kolesari GL. Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo. Am J Obstet Gynecol. 1994 Aug;171(2):501-6. PubMed PMID: 8059831.

9: Ankermann H. [The problem of the characterization of butoxamine as a specific antagonist of the metabolic effects of sympathomimetics]. Biomed Biochim Acta. 1985;44(4):645-8. German. PubMed PMID: 4026819.

10: Kather H, Simon B. Effects of salbutamol and butoxamine on the human fat cell adenylate cyclase. Horm Metab Res. 1980 Dec;12(12):695-7. PubMed PMID: 6259042.

11: Mondal A, Takehara A, Aizawa S, Tanaka T, Fujitsuka N, Hattori T, Sakai T, Sakata I. Rikkunshito induces gastric relaxation via the β-adrenergic pathway in Suncus murinus. Neurogastroenterol Motil. 2015 Jun;27(6):875-84. doi: 10.1111/nmo.12564. Epub 2015 Apr 5. PubMed PMID: 25846270.

12: Zhang C, Rui YY, Zhou YY, Ju Z, Zhang HH, Hu CY, Xiao Y, Xu GY. Adrenergic β2-receptors mediates visceral hypersensitivity induced by heterotypic intermittent stress in rats. PLoS One. 2014 Apr 14;9(4):e94726. doi: 10.1371/journal.pone.0094726. eCollection 2014. PubMed PMID: 24733123; PubMed Central PMCID: PMC3986230.

13: Peng XY, Huang Y, Wang XL, Cao LF, Chen LH, Luo WF, Liu T. Adrenergic β2-receptor mediates itch hypersensitivity following heterotypic chronic stress in rats. Neuroreport. 2015 Dec 2;26(17):1003-10. doi: 10.1097/WNR.0000000000000458. PubMed PMID: 26426856.

14: Zhang Y, Guan Z, Reader B, Shawler T, Mandrekar-Colucci S, Huang K, Weil Z, Bratasz A, Wells J, Powell ND, Sheridan JF, Whitacre CC, Rabchevsky AG, Nash MS, Popovich PG. Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci. 2013 Aug 7;33(32):12970-81. doi: 10.1523/JNEUROSCI.1974-13.2013. PubMed PMID: 23926252; PubMed Central PMCID: PMC3735880.

15: Zlotnik A, Klin Y, Gruenbaum BF, Gruenbaum SE, Ohayon S, Boyko M, Sheiner E, Aricha-Tamir B, Shapira Y, Teichberg VI. The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection. Neurochem Res. 2011 May;36(5):732-8. doi: 10.1007/s11064-010-0388-8. Epub 2011 Jan 5. PubMed PMID: 21207137.

16: Gilbert EF, Bruyere HJ Jr, Ishikawa S, Cheung MO, Hodach RJ. The effect of practolol and butoxamine on aortic arch malformation in beta adrenoreceptor stimulated chick embryos. Teratology. 1977 Jun;15(3):317-23. PubMed PMID: 196355.

17: Sugarman A, Kahn T. Calcium channel blockers enhance extrarenal potassium disposal in the rat. Am J Physiol. 1986 Apr;250(4 Pt 2):F695-701. PubMed PMID: 3083698.

18: Goldman JM, Hadley ME. The effect of butoxamine, N-isopropylmethoxamine and salbutamol (AH-3365) on melanophore beta-adrenergic receptors. J Pharm Pharmacol. 1969 Dec;21(12):854-5. PubMed PMID: 4391059.

19: Kamio N, Suzuki T, Watanabe Y, Suhara Y, Osakabe N. A single oral dose of flavan-3-ols enhances energy expenditure by sympathetic nerve stimulation in mice. Free Radic Biol Med. 2016 Feb;91:256-63. doi: 10.1016/j.freeradbiomed.2015.12.030. Epub 2015 Dec 29. PubMed PMID: 26738802.

20: Wilkenfeld BE, Levy B. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors. Arch Int Pharmacodyn Ther. 1968 Nov;176(1):218-32. PubMed PMID: 5709786.

Your view history

Butoxamine hydrochloride featured